A PET-derived biomarker called metabolic tumor volume more accurately predicts progression-free survival in large B-cell lymphoma patients than the established International Prognostic Index.
← News
Science Breakthroughs Science Breakthroughs Knowledge
PET biomarker outperforms established risk score in predicting survival for large B-cell lymphoma patients
Metabolic Tumor Volume From PET Imaging Biomarker type
Large B-Cell Lymphoma Condition studied
More Accurate Progression-Free Survival Prediction Key advantage
Enables Therapy Individualization Clinical benefit